InvestorsHub Logo
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: ghmm post# 459

Thursday, 10/15/2009 3:51:36 PM

Thursday, October 15, 2009 3:51:36 PM

Post# of 3991
I don't think Shire has capacity for more than 300 patients (US average dose) now, and it is likely to remain limited until its new manufacturing facility will fully function in 2012. Protalix said it will have enough capacity to supply 1,000 patients (US dosing) at launch and it can scale production more rapidly than Shire. However, I doubt Protalix will reach its capacity limit as its immediate market are the 400 Israelis patients.

Let's give chaperones a rest and wait for the data.

Enjoy your weekend.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PLX News